Related Experiment Video

Updated: Aug 23, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Risk stratification for the prevention of cardiovascular complications of hypertension

Xavier Girerd1, Philippe Giral

  • 1Department of Endocrinolgy and Metabolism, Cardiovascular Preventive Unit, Hôpital de La Pitié-Salpêtrière, Paris, France. xavier.girerd@psl.ap-hop-paris.fr

Current Medical Research and Opinion
|July 22, 2004
PubMed

Insights

Arterial hypertension increases risk for coronary artery disease and stroke. Combining antihypertensive therapy with statins significantly reduces cardiovascular events in high-risk patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Preventive Medicine

Background:

  • Arterial hypertension is a significant risk factor for coronary artery disease (CAD) and stroke.
  • Current treatment decisions for hypertension often rely solely on blood pressure levels.
  • Cardiovascular risk assessment is crucial for personalized hypertension management.

Purpose of the Study:

  • To review major trials and emphasize the need for comprehensive cardiovascular risk assessment in hypertensive patients.
  • To analyze the differential efficacy of antihypertensive drugs in preventing coronary versus cerebrovascular events.
  • To evaluate the role of statins in cardiovascular risk reduction for hypertensive individuals.

Main Methods:

  • Cross-sectional analysis of major clinical trials on hypertension and cardiovascular outcomes.
  • Meta-analysis of studies investigating the impact of blood pressure reduction on stroke and coronary events.
  • Review of controlled trials evaluating the efficacy of statins in preventing coronary disease.

Main Results:

  • Hypertensive patients have a 2-3 times higher coronary risk than cerebrovascular risk.
  • Antihypertensive drugs are more effective in preventing cerebrovascular events than CAD for the same blood pressure reduction.
  • A 2 mmHg systolic blood pressure reduction lowers stroke events by 25%; 5 mmHg is needed for coronary event prevention.
  • Statins are highly effective in preventing coronary disease.

Conclusions:

  • An integrated strategy of antihypertensive therapy and statin prescription is optimal for cardiovascular risk reduction in hypertensive patients.
  • The ASCOT trial demonstrated significant reduction in coronary events with combined therapy.
  • Personalized cardiovascular risk assessment should guide treatment decisions for hypertension.

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.